Company Xynomic Pharmaceuticals Holdings, Inc. Nasdaq

BCACU

VGG1142P1201

Pharmaceuticals

Business Summary

Share class

Company contact information

Sector

Sector Biopharmaceuticals

Delayed Nasdaq Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-19.05%

2021	Xu-Nuo Pharma, Inc. acquired the remaining 2% stake in Xynomic Pharmaceuticals Holdings, Inc..	CI
2020	Xynomic Pharmaceuticals Holdings, Inc. Announces Resignation of Richard Peidong Wu as Independent Director and the Chairman of the Audit Committee	CI

XYNOMIC PHARMACEUTICALS HOLDINGS, INC. is a China-based biopharmaceutical company. The Company, together with its subsidiaries, are principally engaged in in-licensing, developing and commercializing oncology drug candidates in the People's Republic of China (PRC), the United States, and rest of the world. To date, the Company has not yet generated any revenue from product sales.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	46,273,846	9,195,670 ( 19.87 %)	0	19.87 %

Xynomic Pharmaceuticals Holdings, Inc.

K. Wah Centre 1010 Middle Road

200031, Shanghai

http://xynomicpharma.com/en/506-11/

address Xynomic Pharmaceuticals Holdings, Inc.(BCACU)

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Biopharmaceuticals

	1st Jan change	Capi.
CSL LIMITED	-3.20%	86.16B
SAMSUNG BIOLOGICS CO.,LTD.	+2.76%	40.17B
BIOGEN INC.	-17.49%	31.47B
UCB	+54.44%	25.24B
BIOMARIN PHARMACEUTICAL INC.	-13.13%	15.82B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9.12%	11.96B
INCYTE CORPORATION	-15.45%	11.89B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-42.56%	11.61B
SWEDISH ORPHAN BIOVITRUM AB	+4.87%	8.84B

Biopharmaceuticals